News Article

Unintended Consequences of Ohio's S.B. 319 Could Reduce Access to Addiction Treatment

Tuesday, December 27, 2016

by The National Law Review

In the midst of an acknowledged opioid epidemic and public health crisis for treatment resources and options, the Ohio General Assembly has approved Senate Bill 319 (S.B. 319) which contains provisions which are expected to aid in the response to this crisis. However, one provision of this new law will in all likelihood reduce access to Suboxone clinics operating in the State of Ohio. S.B. 319 does this by establishing State of Ohio Board of Pharmacy (Pharmacy Board) licensure requirements for locations providing Suboxone treatment to patients suffering from opioid and heroin abuse and dependence even if such locations do not store, possess, or distribute any medications. S.B. 319 is awaiting Governor Kasich’s signature.

http://www.natlawreview.com/article/unintended-consequences-ohio-s-sb-319-could-reduce-access-to-addiction-treatment